36
Participants
Start Date
April 30, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
April 30, 2009
KB001
Single low-dose, administered intravenously
KB001
Single high-dose, administered intravenously
Placebo
Placebo single-dose, administered intravenously
Multiple Cities
Lead Sponsor
Humanigen, Inc.
INDUSTRY